Clinical trials
Death clinical trials
Below are recruiting death clinical trials, each written for real people, not researchers. We’re tracking 148 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06253000Recruiting
Heat vs. Freezing for the Back of the Heart
This trial tests two ways to treat the back wall of the heart's left chamber in people with stubborn atrial fibrillation. It compares radiofrequency (heat) and cryoablation (freezing) to see which is safer and works better.
MoscowAges 18–80 - NCT06240715Recruiting
Umbilical cord milking for premature babies who need help at birth
This study tests whether gently squeezing the umbilical cord before clamping it (called cord milking) helps premature babies who are not vigorous at birth. It is being done in hospitals with fewer resources to find safe and effective ways to improve oxygen and blood flow right after delivery.
Belagavi, KarnatakaAges birth–10 minutes - NCT06170788RecruitingPhase 3
New Two-Drug Immunotherapy Combo vs. Standard Immunotherapy for Advanced Lung Cancer
This study compares a new combination of two immunotherapy drugs (sacituzumab tirumotecan plus pembrolizumab) versus pembrolizumab alone for people with advanced non-small cell lung cancer that has a high PD-L1 level (≥50%) and has not been treated yet. The goal is to see if the combination works better than the standard single immunotherapy.
Phoenix, ArizonaAges 18 years+ - NCT06136260Recruiting
Grief support study for parents after child's sudden death
This study offers two types of support for parents or caregivers grieving the unexpected or traumatic death of a child under 25. It compares which approach works best in helping families cope with their loss.
Chicago, IllinoisAges 18 years+ - NCT06087224Recruiting
Telemedicine for newborn emergencies
This study tests if a telemedicine system helps community hospital teams care for newborns who need advanced help right after birth. It may improve care for premature babies or those needing breathing or chest support.
Anchorage, AlaskaAges birth+ - NCT05883540RecruitingPhase 2
LSD therapy in palliative care for comfort and well-being
This Phase 2 study tests how LSD may affect comfort and quality of life for people with advanced or end-stage life-limiting illness. It also checks whether the medicine is safe and can be given in a controlled way in palliative care settings.
BaselAges 22 years+ - NCT05890716Recruiting
AI analyzes your ECG to help in high-risk heart rhythm cases
This trial uses an AI program to review ECG heart-tracing data collected from short-term monitoring devices. It aims to see whether the AI can better detect concerning heart rhythm patterns in people who are high risk for heart rhythm or heart problems.
Groningen, Provincie GroningenAges 4 years+ - NCT05874362Recruiting
Study grief after violent loss and how time is perceived
This study looks at how people who recently lost a close family member to a violent death experience grief, including how they perceive time. It may help researchers understand these effects and better plan future support for bereaved people.
BronAges 18–65 - NCT05724121Recruiting
Study heart rhythm changes during BTK or venetoclax treatment
This observational study tracks how your heart rhythm (heartbeat pattern) changes while you take a BTK inhibitor or venetoclax. It may help doctors better understand heart rhythm risks in people receiving these cancer-related medicines.
Bethesda, MarylandAges 18–110 - NCT05678699Recruiting
How Medicaid programs affect serious pregnancy complications
This study looks at how Medicaid rules and programs affect serious health problems during pregnancy and after birth. It may include women on Medicaid and also doulas and health-plan leaders, to help improve care for mothers.
Pittsburgh, PennsylvaniaAges Any age - NCT05678166Recruiting
Testing a blood marker to predict worsening lung mycobacterial disease
This study checks whether a blood test called soluble programmed death-1 can help predict how nodular-bronchiectatic nontuberculous mycobacterial (NTM) lung disease will progress. Results may help doctors monitor patients more accurately and decide when to treat or follow more closely.
TaipeiAges 20 years+ - NCT05609123Recruiting
Study of blood-surface damage in brain-dead organ donors
This study looks at damage to a protective layer on blood vessels in people who have been declared brain dead. The goal is to better understand what happens in brain-dead donors, which could help improve organ donation care and outcomes.
Hradec KrálovéAges 18 years+ - NCT05585411Recruiting
Pacemaker type test to reduce heart worsening and death risk
This study compares two pacemaker pacing strategies—left-sided “bundle branch area” pacing versus right-sided ventricular pacing. It aims to see which approach better prevents heart failure getting worse and reduces abnormal timing between heart chambers over time.
Bucheon-siAges 19 years+ - NCT05562830RecruitingPhase 1/Phase 2
Study for bladder or urinary tract cancer after PD-1 failure
This Phase 1/2 study tests investigational cancer treatment(s) in people with locally advanced or metastatic urothelial cancer that has not responded to PD-1/PD-L1 immunotherapy. It may help by trying a new approach after prior checkpoint treatment has stopped working or the cancer returns.
Orange, CaliforniaAges 18 years+ - NCT05466123Enrolling by invitation
Virtual reality experience for people near the end of life
This trial is testing a virtual reality (“VR”) experience for people who are nearing the end of life and already receiving comfort-focused care. It may help you and your care team understand whether VR can improve comfort, feelings, or quality of life during this time.
Jacksonville, FloridaAges 18 years+ - NCT05446272Recruiting
Helps premature babies breathe during breathing tube removal
This trial tests a breathing-support method (called DIVA) to help premature babies breathe safely when the breathing tube is taken out. It may help more babies transition off the ventilator and avoid breathing problems during extubation.
Little Rock, ArkansasAges birth–2 months - NCT05328024Recruiting
Testing who benefits from anti–PD-1 immunotherapy in head cancer
This study looks for signs in your tumor that can predict how well anti–PD-1 immunotherapy will work for certain head and neck cancers. You may benefit by helping doctors match the right treatment to the right patients.
Strasbourg, FranceAges 18 years+ - NCT05306327Recruiting
Study nerves and breathing after stopping life support
This trial looks at how a person’s nervous system signals change right after life support is withdrawn. It may help doctors better understand what to expect during end-of-life care and how to monitor the process.
Calgary, AlbertaAges 18 years+ - NCT05199025Recruiting
Study of blood and lab markers around major surgeries
This study checks blood and other lab “biomarkers” during the time before and after major surgeries to see if they can help guide perioperative care. You might be eligible if you are having certain planned heart, lung, GI, or blood-vessel surgeries and can give informed consent.
Breda, North BrabantAges 18 years+ - NCT04777994RecruitingPhase 1
Drug ABBV-CLS-484 for advanced cancers that lack options
This Phase 1 trial tests ABBV-CLS-484 in people with advanced or metastatic tumors when standard treatments have not worked or aren’t available. Because it’s an early study, the main goal is to find a safe dose and see how the cancer responds in different cancer types.
Tucson, ArizonaAges 18 years+ - NCT04356326RecruitingPhase 3
Aspirin to prevent complications in pregnancy with chronic high blood pressure
This trial studies whether taking acetyl salicylic acid (aspirin) during pregnancy can reduce problems caused by chronic high blood pressure. It focuses on pregnant people already known to have high blood pressure before or early in pregnancy.
BordeauxAges 18 years+ - NCT04189822Enrolling by invitation
Heart rhythm genetic registry and blood sample bio bank
This study is building a Canadian database and tissue/blood bank for people and families with inherited heart rhythm conditions (and some inherited heart muscle diseases). It collects consented health and genetic information to help researchers better understand who is at risk and how these conditions work.
Vancouver, British ColumbiaAges Any age - NCT01076660Recruiting
MRI study to predict sudden cardiac death risk
This trial uses heart MRI images and measurements to look for warning signs that could predict sudden cardiac death. It focuses on people with significantly reduced heart pumping function who are being considered for an ICD to prevent sudden death.
Newark, DelawareAges 21–80 - NCT03736889RecruitingPhase 2
Tislelizumab for MSI-H or dMMR solid tumors after prior treatment
This trial studies tislelizumab, an immune treatment that blocks PD-1, in people with MSI-H or dMMR solid tumors that cannot be fully removed or have spread, after other treatment has already been tried. It may help your immune system recognize and fight the cancer.
Hefei, AnhuiAges 18 years+
Hear when a new Death trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for death?
- Yes. Clin2 currently lists 148 recruiting death studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a death trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a death trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.